Literature DB >> 24401788

Role of epidermal growth factor receptor in vascular structure and function.

Barbara Schreier1, Michael Gekle, Claudia Grossmann.   

Abstract

PURPOSE OF THE REVIEW: The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase with a wide implication in tumor biology, wound healing and development. Besides acting as a growth factor receptor activated by ligands such as EGF, the EGFR can also be transactivated and thereby mediate cross-talk with different signaling pathways. The aim of this review is to illustrate the Janus-faced function of the EGFR in the vasculature with its relevance for vascular biology and disease. RECENT
FINDINGS: Over recent years, the number of identified signaling partners of the EGFR has steadily increased, as have the biological processes in which the EGFR is thought to be involved. Recently, new models have allowed investigation of EGFR effects in vivo, shedding some light on the overall function of the EGFR in the vasculature. At the same time, EGFR inhibitors and antibodies have become increasingly established in cancer therapy, providing potential therapeutic tools for decreasing EGFR signaling.
SUMMARY: The EGFR is a versatile signaling pathway integrator associated with vascular homeostasis and disease. In addition to modulating basal vascular tone and tissue homeostasis, the EGFR also seems to be involved in proinflammatory, proliferative, migratory and remodeling processes, with enhanced deposition of extracellular matrix components, thereby promoting vascular diseases such as hypertension or atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24401788     DOI: 10.1097/01.mnh.0000441152.62943.29

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  25 in total

1.  The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells.

Authors:  Raúl R Rodrigues-Diez; Ana Belen Garcia-Redondo; Macarena Orejudo; Raquel Rodrigues-Diez; Ana Maria Briones; Enrique Bosch-Panadero; Gyorgy Kery; Janos Pato; Alberto Ortiz; Mercedes Salaices; Jesus Egido; Marta Ruiz-Ortega
Journal:  Antioxid Redox Signal       Date:  2015-01-01       Impact factor: 8.401

2.  Purpuric Drug Eruptions Caused by Epidermal Growth Factor Receptor Inhibitors for Non-Small Cell Lung Cancer: A Clinicopathologic Study of 32 Cases.

Authors:  Yung-Tsu Cho; Kai-Lung Chen; Yi-Shuan Sheen; Che-Wen Yang; Jau-Yu Liau; Yu-Pin Cheng; Chia-Yu Chu
Journal:  JAMA Dermatol       Date:  2017-09-01       Impact factor: 10.282

3.  Integrative gene ontology and network analysis of coronary artery disease associated genes suggests potential role of ErbB pathway gene EGFR.

Authors:  Madankumar Ghatge; Jiny Nair; Ankit Sharma; Rajani Kanth Vangala
Journal:  Mol Med Rep       Date:  2018-01-08       Impact factor: 2.952

4.  The soluble protease ADAMDEC1 released from activated platelets hydrolyzes platelet membrane pro-epidermal growth factor (EGF) to active high-molecular-weight EGF.

Authors:  Rui Chen; Ge Jin; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2017-04-28       Impact factor: 5.157

5.  The Functional Interaction of EGFR with AT1R or TP in Primary Vascular Smooth Muscle Cells Triggers a Synergistic Regulation of Gene Expression.

Authors:  Virginie Dubourg; Barbara Schreier; Gerald Schwerdt; Sindy Rabe; Ralf A Benndorf; Michael Gekle
Journal:  Cells       Date:  2022-06-16       Impact factor: 7.666

Review 6.  Tyrosine Kinase Inhibitors and Vascular Toxicity: Impetus for a Classification System?

Authors:  Joerg Herrmann
Journal:  Curr Oncol Rep       Date:  2016-06       Impact factor: 5.075

7.  Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System.

Authors:  Steven J Forrester; Tatsuo Kawai; Shannon O'Brien; Walter Thomas; Raymond C Harris; Satoru Eguchi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-11-09       Impact factor: 13.820

8.  Genomic and proteomic evaluation of tissue quality of porcine wounds treated with negative pressure wound therapy in continuous, noncontinuous, and instillation modes.

Authors:  Kathleen L Derrick; M Christian Lessing
Journal:  Eplasty       Date:  2014-12-04

9.  Composites of Nucleic Acids and Boron Clusters (C2B10H12) as Functional Nanoparticles for Downregulation of EGFR Oncogene in Cancer Cells.

Authors:  Damian Kaniowski; Katarzyna Ebenryter-Olbińska; Katarzyna Kulik; Justyna Suwara; Wojciech Cypryk; Agata Jakóbik-Kolon; Zbigniew Leśnikowski; Barbara Nawrot
Journal:  Int J Mol Sci       Date:  2021-05-04       Impact factor: 5.923

10.  Nasal administration of interleukin-33 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma surrogate.

Authors:  Shan Shan; Yan Li; Jingjing Wang; Zhe Lv; Dawei Yi; Qiong Huang; Chris J Corrigan; Wei Wang; Zhang Quangeng; Sun Ying
Journal:  Immunology       Date:  2016-03-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.